#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	519	11872	16S	1529	1529	99.87	16S.l15.c4.ctg.1	1896	970.9	0	.	n	.	0	G1207A	SNP	1207	1207	G	1429	1429	A	1321	A	751	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	519	11872	16S	1529	1529	99.87	16S.l15.c4.ctg.1	1896	970.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1672	1672	T	1035	T	562	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	519	11872	16S	1529	1529	99.87	16S.l15.c4.ctg.1	1896	970.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1406	1406	C	1219	C,A	689,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	519	11872	16S	1529	310	99.68	16S.l15.c4.ctg.2	310	134.8	0	.	n	.	0	G642A	SNP	642	642	G	156	156	A	90	A,G	42,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22086	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3544	957.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1578	1578	A	973	A	550	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22086	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3544	957.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2212	2212	C	1009	C	579	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22086	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3544	957.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2286	2286	A	1133	A	660	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22086	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3544	957.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2838	2838	C	1121	C,A,G	653,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	730	folP	852	852	99.77	folP.l15.c4.ctg.1	1679	73.1	0	.	p	.	0	D71H	NONSYN	211	213	GAT	728	730	CAT	88;90;90	C;A;T	52;52;52	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	730	folP	852	852	99.77	folP.l15.c4.ctg.1	1679	73.1	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1127	1129	GTA	159;157;157	G;T;A	91;87;87	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	730	folP	852	852	99.77	folP.l15.c4.ctg.1	1679	73.1	1	SNP	p	R228S	0	.	.	682	684	CGC	1199	1201	CGC	136;136;135	C;G;C	76;77;71	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	655	1796	gyrA	2751	2751	99.71	gyrA.l6.c17.ctg.1	3303	86.4	0	.	p	.	0	A125S	NONSYN	373	375	GCC	694	696	TCC	122;126;122	T;C;C	67;73;71	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	655	1796	gyrA	2751	2751	99.71	gyrA.l6.c17.ctg.1	3303	86.4	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1069	1071	ATA	74;71;71	A;T;A	44;43;41	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	655	1796	gyrA	2751	2751	99.71	gyrA.l6.c17.ctg.1	3303	86.4	0	.	p	.	0	T746P	NONSYN	2236	2238	ACC	2557	2559	CCC	43;43;43	C,A;C;C	1,22;26;26	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	655	1796	gyrA	2751	2751	99.71	gyrA.l6.c17.ctg.1	3303	86.4	0	.	p	.	0	L770W	NONSYN	2308	2310	TTG	2629	2631	TGG	23;23;23	T;G,T;G	12;0,14;10	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	655	1796	gyrA	2751	2751	99.71	gyrA.l6.c17.ctg.1	3303	86.4	1	SNP	p	S91F	0	.	.	271	273	TCC	592	594	TCC	127;129;129	T;C;C	74;73;75	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	655	1796	gyrA	2751	2751	99.71	gyrA.l6.c17.ctg.1	3303	86.4	1	SNP	p	D95G	0	.	.	283	285	GAC	604	606	GAC	139;141;141	G;A;C	79;78;81	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	655	1796	gyrA	2751	2751	99.71	gyrA.l6.c17.ctg.1	3303	86.4	1	SNP	p	D95N	0	.	.	283	285	GAC	604	606	GAC	139;141;141	G;A;C	79;78;81	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	655	1796	gyrA	2751	169	98.82	gyrA.l6.c17.ctg.2	496	9.8	0	.	p	.	0	T2P	NONSYN	4	6	ACC	267	269	CCC	24;24;24	C,A;C;C	0,15;16;16	.	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	612	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1250	81.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	408	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	698	89.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1840	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2895	105.6	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1503	1505	GCA	101;105;107	G;C;A	64;63;65	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1840	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2895	105.6	1	SNP	p	D86N	0	.	.	256	258	GAC	456	458	GAC	143;143;142	G;A;C	77;81;80	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1840	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2895	105.6	1	SNP	p	S87I	0	.	.	259	261	AGT	459	461	AGT	142;142;142	A;G;T,G	81;81;82,1	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1840	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2895	105.6	1	SNP	p	S87R	0	.	.	259	261	AGT	459	461	AGT	142;142;142	A;G;T,G	81;81;82,1	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1840	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2895	105.6	1	SNP	p	S87W	0	.	.	259	261	AGT	459	461	AGT	142;142;142	A;G;T,G	81;81;82,1	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1840	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2895	105.6	1	SNP	p	S88P	0	.	.	262	264	TCC	462	464	TCC	142;139;139	T;C;C	79;76;81	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1576	parE	1986	1986	99.9	parE.l15.c4.ctg.1	2362	110.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1439	1441	GGC	67;67;66	G;G;C	45;43;38	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.40.001	penA.40.001	1	1	27	2078	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2185	146.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1198	1200	GCA	243;248;248	G;C;A	144;148;153	penA.40.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.40.001	penA.40.001	1	1	27	2078	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2185	146.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1201	1203	ATC	250;250;250	A;T;C,A	149;148;149,1	penA.40.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.40.001	penA.40.001	1	1	27	2078	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2185	146.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1213	1215	GTG	250;252;252	G;T;G	152;150;149	penA.40.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.40.001	penA.40.001	1	1	27	2078	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2185	146.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1213	1215	GTG	250;252;252	G;T;G	152;150;149	penA.40.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.40.001	penA.40.001	1	1	27	2078	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2185	146.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1717	1719	ACC	114;114;108	A;C;C	67;73;69	penA.40.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.40.001	penA.40.001	1	1	27	2078	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2185	146.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1771	1773	GCG	74;74;74	G;C,G;G	41;40,1;43	penA.40.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.40.001	penA.40.001	1	1	27	2078	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2185	146.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1771	1773	GCG	74;74;74	G;C,G;G	41;40,1;43	penA.40.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.40.001	penA.40.001	1	1	27	2078	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2185	146.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1894	1896	GGC	67;69;69	G;G;C	42;47;41	penA.40.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.40.001	penA.40.001	1	1	27	2078	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2185	146.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1903	1905	GGC	53;53;47	G;G;C	35;35;28	penA.40.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.40.001	penA.40.001	1	1	27	2078	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2185	146.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1921	1923	CCG	55;55;54	C,G;C;G	30,1;27;26	penA.40.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	3662	ponA	2397	2397	99.96	ponA.l6.c17.ctg.1	3171	171.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	850	porA	1146	1146	99.83	porA.l6.c17.ctg.1	1753	77.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	611	611	C	43	C	24	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	1276	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1464	141.8	0	.	p	.	0	T18M	NONSYN	52	54	ACG	210	212	ATG	120;119;121	A;T;G	65;56;61	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	1276	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1464	141.8	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	585	587	CAA	156;154;156	C;A,C;A,C	89;87,1;89,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	1276	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1464	141.8	0	.	p	.	0	E212D	NONSYN	634	636	GAA	792	794	GAT	150;151;152	G;A;T	95;94;94	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	1276	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1464	141.8	0	.	p	.	0	H213D	NONSYN	637	639	CAT	795	797	GAT	152;152;152	G,T;A;T	91,1;94;91	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	1276	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1464	141.8	0	.	p	.	0	V215A	NONSYN	643	645	GTT	801	803	GCT	157;155;155	G;C;T	94;98;96	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	1276	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1464	141.8	0	.	p	.	0	S220T	NONSYN	658	660	AGC	816	818	ACT	183;184;184	A;C;T	111;110;107	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	1276	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1464	141.8	0	.	p	.	0	R257M	NONSYN	769	771	AGG	927	929	ATG	209;207;210	A;T;G	117;115;116	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	1276	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1464	141.8	0	.	p	.	0	R258S	NONSYN	772	774	AGG	930	932	AGC	208;205;205	A;G;C	118;116;115	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	1276	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1464	141.8	0	.	p	.	0	A259G	NONSYN	775	777	GCT	933	935	GGT	201;203;201	G;G;T	115;116;112	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	1276	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1464	141.8	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1047	1049	AAC	179;178;182	A;A;C	99;97;103	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	1276	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1464	141.8	1	SNP	p	G120K	0	.	.	358	360	GGC	516	518	GGC	144;146;146	G;G;C	89;89;87	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	6158	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4567	216.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1786	1788	CAT	218;218;219	C;A;T	127;126;127	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	432	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	710	97.4	1	SNP	p	V57M	0	.	.	169	171	GTG	373	375	GTG	174;170;174	G;T;G	102;101;101	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
